Autopsy report · NCT01104480

Tocilizumab for Relapsing Polychondritis

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Tocilizumab was licenced in Canada for children, so the study was not necessary”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: McMaster Children's Hospital
Sponsor type: University, hospital or other
Conditions: Relapsing Polychondritis
Interventions: Tocilizumab
Participants: 0
Sites: 1
Countries: Canada

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.